1 year return (CAGR)
-5.84%
Skye Bioscience, Inc. Common Stock Exchange (NASDAQ, USD)
SKYE
1.45
-0.12 (-7.64%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-17.69%
5 year return (CAGR)
-39.06%
10 year return (CAGR)
-35.56%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
6.42M
Price/Sales
-
Ent value
9.88M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-27.60%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.58 |
| Daily high | 1.58 |
| Daily low | 1.45 |
| Daily Volume | 16K |
| All-time high | 1937.50 |
| 1y analyst estimate | 68.00 |
| Beta | 2.90 |
| EPS (TTM) | -10.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SKYE | S&P500 | |
| Current price drop from All-time high | -99.93% | -1.21% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 20 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -95.06% | -10.65% |
| Avg time to new high | 596 days | 12 days |
| Max time to new high | 2970 days | 1805 days |
News
